[HTML][HTML] Altered brain cholinergic and synaptic markers in obese Zucker rats

I Martinelli, D Tomassoni, P Roy, F Amenta… - Cells, 2021 - mdpi.com
I Martinelli, D Tomassoni, P Roy, F Amenta, SK Tayebati
Cells, 2021mdpi.com
The association between obesity and loss of cognitive performance has been recognized.
Although there are data regarding the metabolic alterations in obese conditions and the
development of neuroinflammation, no clear evidence concerning obesity-related
cholinergic and synaptic impairments in the frontal cortex and hippocampus has been
reported yet. Here, we investigate different cholinergic and synaptic markers in 12-, 16-, and
20-week-old obese Zucker rats (OZRs) compared with lean littermate rats (LZRs), using …
The association between obesity and loss of cognitive performance has been recognized. Although there are data regarding the metabolic alterations in obese conditions and the development of neuroinflammation, no clear evidence concerning obesity-related cholinergic and synaptic impairments in the frontal cortex and hippocampus has been reported yet. Here, we investigate different cholinergic and synaptic markers in 12-, 16-, and 20-week-old obese Zucker rats (OZRs) compared with lean littermate rats (LZRs), using immunochemical and immunohistochemical analysis. Consequently, OZRs showed body weight gain, hypertension, and dysmetabolism. In 20-week-old OZRs, the reduction of vesicular acetylcholine transporter (VAChT) and alpha7 nicotinic acetylcholine receptors (α7nAChR) occurred both in the frontal cortex and in the hippocampus, suggesting a cognitive dysfunction due to obesity and aging. Among the muscarinic receptors analyzed, the level of expression of type 1 (mAChR1) was lower in the hippocampus of the older OZRs. Finally, we showed synaptic dysfunctions in OZRs, with a reduction of synaptophysin (SYP) and synaptic vesicle glycoprotein 2B (SV2B) in 20-week-old OZRs, both in the frontal cortex and in the hippocampus. Taken together, our data suggest specific alterations of cholinergic and synaptic markers that can be targeted to prevent cognitive deficits related to obesity and aging.
MDPI